Cargando…
A NEW COPPER (II)-IMIDAZOLE DERIVATIVE EFFECTIVELY INHIBITS REPLICATION OF DENV-2 IN VERO CELL
BACKGROUND: Dengue is a kind of infectious disease that was distributed in the tropical and sub-tropical areas. To date, there is no clinically approved dengue vaccine or antiviral for humans, even though there have been great efforts towards this end. Therefore, finding the effective compound again...
Autores principales: | Sucipto, Teguh Hari, Churrotin, Siti, Setyawati, Harsasi, Martak, Fahimah, Mulyatno, Kris Cahyo, Amarullah, Ilham Harlan, Kotaki, Tomohiro, Kameoka, Masanori, Yotopranoto, Subagyo, Soegijanto, and Soegeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
African Traditional Herbal Medicine Supporters Initiative (ATHMSI)
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876766/ https://www.ncbi.nlm.nih.gov/pubmed/29619441 http://dx.doi.org/10.2101/Ajid.12v1S.17 |
Ejemplares similares
-
Phylogenetic Analysis of Dengue Virus in Bangkalan, Madura Island, East Java Province, Indonesia
por: Sucipto, Teguh Hari, et al.
Publicado: (2018) -
Inhibition of dengue virus serotype 2 in Vero cells with [Cu(2,4,5-triphenyl-1H-imidazole) 2(H2O)2].Cl2
por: Sucipto, Teguh H., et al.
Publicado: (2020) -
An affinity-matured human monoclonal antibody targeting fusion loop epitope of dengue virus with in vivo therapeutic potency
por: Kotaki, Tomohiro, et al.
Publicado: (2021) -
Potential Misdiagnosis between COVID-19 and Dengue Infection Using Rapid Serological Test
por: Khairunisa, Siti Qamariyah, et al.
Publicado: (2021) -
How should Indonesia consider its neglected tropical diseases in the COVID-19 era? Hopes and challenges (Review)
por: Fauziyah, Shifa, et al.
Publicado: (2021)